Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Catena Pharmaceuticals Inc.
DescriptionLysophosphatidic acid (LPA) receptor antagonist
Molecular Target Lysophosphatidic acid (LPA) receptor
Mechanism of ActionLysophosphatidic acid receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today